Business, Lifestyle, Media & Communications, Technology

Everest Group recognizes Visonet as star performer in its Microsoft Business Applications Services PEAK Matrix® 2025

CRANBURY, N.J. — Visionet has been recognized as a Star Performer and Major Contender in Everest Group’s Microsoft Business Applications Services PEAK Matrix® Assessment 2025, focused on CRM and ERP services. This recognition reflects Visionet’s momentum in the Microsoft ecosystem, backed by proven Dynamics

Business, Cultural Corner, Media & Communications, Opinions & Philosophy

Robert Half recognized as one of Fortune’s Best Workplaces in Consulting & Professional Services 2025

MENLO PARK, Calif. — PRNewswire — Global talent solutions and business consulting firm Robert Half (NYSE: RHI) has recently been honored as one of Fortune’s 2025 Best Workplaces in Consulting & Professional Services™. This prestigious honor highlights the company’s reputation as an employer of

Cultural Corner, Health Care, Law & Legal, Science

Invisible Wounds Foundation launches Brain Health Collaborative to combat traumatic brain injury in service members and to prevent military suicides

CHICAGO — PRNewswire — In advance to the 24th anniversary of 9-11, the Invisible Wounds Foundation, on Monday, announced the launch of its Brain Health Collaborative. The Invisible Wounds Foundation is a Chicago-based nonprofit foundation dedicated to advancing the science to diagnose, treat,

Health Care, Law & Legal, Lifestyle, Science

VANDA Pharmaceuticals recently announces FDA grants Orphan Drug Designation for VGT-1849B, a novel and selective candidate for the treatment of Polycythemia Vera

WASHINGTON — PRNewswire — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) on Aug. 28, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of polycythemia vera (PV).